Researchers are developing vaccines and fresh drug approaches to prevent and treat recurring infections without antibiotics.
The Food and Drug Administration recently approved Pivya (pivmecillinam) to treat uncomplicated UTIs in female adults.
A stinging sensation when you pee, cramping in your lower belly, an intense urge to tinkle all day long. Anyone who’s ever ...
A study in eClinicalMedicine explores the relationship between gut microbiota, urinary tract colonization, and recurrent ...
Study shows raw meat fed to animals causes antibiotic resistance to critical antibiotics, which can also be acquired by pet ...
The US Food and Drug Administration has approved pivmecillinam (Pivya) tablets to treat uncomplicated urinary tract ...
The approval was based on data from 3 phase 3 trials which compared the efficacy of different dosing regimens of ...
Pivmecillinam, which has been used in Europe for decades, will become available next year to women 18 and older.
With a rise in antibiotic-resistant cases across the UK, here's everything you need to know, from how you get Shigella to how ...
The Food and Drug Administration (FDA) has approved Pivya (pivmecillinam) for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (UTIs) caused by ...
The U.S. Food and Drug Administration has approved oral pivmecillinam for the treatment of female adults with uncomplicated ...
April 24 (UPI) --The newly approved oral medication Pivya provides women with another option for treating uncomplicated urinary tract infections, the U.S. Food and Drug Administration announced ...